Please enter subscribe form shortcode

Sur. Dr. Deniz Dehni

  • Area of ​​Expertise: Responsible Manager & Urology Specialist
  • Years of Experience: 15 Years
  • E-mail: [email protected]

About

Deniz Dehni was born on 07 February 1978 in Elazig. He completed his undergraduate education in Ankara University Faculty of Medicine. He completed his PhD in Urology at Ankara Ataturk Training and Research Hospital. He worked at Ankara Ataturk Training and Research Hospital, Department of Urology, Ergani State Hospital, Basari Hospital, Avrupa Hospital and Ota Jinemed Hospital.

Articles:
M.Ademir, K.Agras,D.Dehni, Ö.Kayıgil Prospective comparison of two treatment modalities in benign prostate hyperplazia: alpha-blocker only vs. alpha blocker plus anticholinergic combination. Turkiye Klinikleri J Med Sci 30(2):539-43, 2010. M. Aldemir, K.Agras, K.Ener, D. Dehni, Ö.Kayigil Corpus cavernosum electromyography: could it be a parameter two predict aging . andrologia 2010 Dec;42(6):343-8 M.Aldemir, K.Ener, D.Dehni, K.Agras, Ö.Kayıgil. Evaluation of the relationship between prostate cancer and inflammation markers. Int J Nephrol Urol 2(1): 244-250, 2010. Aldemir M, Dehni D, Agras K, Ener K, , Kayıgil Ö. The value of magnetic resonance imaging in the presence of suspicious bone scintigraphy findings in prostate cancer patients. Urology Bulletin 20, 030-032, 2010. M.Aldemir, D Dehni Evaluation of the factors affecting bone mineral density in prostate cancer patients who received androgen deprivation therapy and who did not. Urology Bulletin, 20, 030-032, 2010. M.Aldemir, D.Dehni, K.Agras,K.Ener, Ö.Kayıgil The value of magnetic resonance imaging in the presence of suspicious bone scintigraphy in prostate cancer patients. 20th National Urology Congress, 2008 Antalya. M.Aldemir, K.Agras, D.Dehni, Ö.Kayıgil Comparison of alpha-blocker alone versus alpha-blocker+tolterodine combination therapy in benign prostatic hyperplasia cases. 20th National Urology Congress, 2008 Antalya. M. Aldemir, D. Dehni, O. Kayigil. Evaluation of the factors affecting bone mineral density in prostate cancer patients receiving androgen deprivation therapy. 9. Urooncology Congress, 2009 Ankara. M.Aldemir, K.Ener, D.Dehni, K.Agras, Ö.Kayıgil Evaluation of the relationship between prostate cancer and serum inflammation markers. 9. Urooncology Congress, 2009 Ankara

Congresses attended:
19. National urology congress, 2006. Andrology Congress, 2007. Continence Society Congress, 2007. Urology Update, 2008. 20. National Urology Congress, 2008. 10. Turkish Pediatric Urology Congress, 2009. Uro-oncology Congress, 2011.

İletişime Geç
💬 Nasıl yardımcı olabiliriz?
Merhaba👋
Nasıl Yardımcı Olabiliriz?